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Gender Differences in the Association between Serum 
γ-Glutamyltransferase and Blood Pressure Change: A Prospective 
Community-Based Cohort Study
We evaluated the gender differences in the relation of baseline serum γ-glutamyltransferase 
(GGT) levels to blood pressure (BP) change during 4 yr. 4,025 normotensive subjects (1,945 
men and 2,080 women) who aged 40-69 yr at baseline participated in the Ansung-Ansan 
cohort of the Korean Genome Epidemiology Study were included. The associations of GGT 
with baseline BP or 4-yr change of BP were evaluated. GGT levels were associated with 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) at baseline after adjusting 
for age, body mass index (BMI), HDL-cholesterol, triglyceride, C-reactive protein (CRP), 
current smoking status and alcohol intake (SBP, β = 1.28, P < 0.001; DBP, β = 1.41, 
P < 0.001). GGT levels were also associated with 4-yr change in BP after adjusting for age, 
BMI, HDL-cholesterol, triglyceride, CRP, current smoking status, alcohol intake and SBP 
(SBP, β = 1.08, P = 0.001; DBP, β = 0.64, P = 0.003). This association was statistically 
significant in men (SBP, β = 1.82, P < 0.001; DBP, β = 1.05, P = 0.001), but not in 
women (SBP, β = 0.38, P = 0.466; DBP, β = -0.37, P = 0.304). Remarkably, this 
association between GGT and BP was significant in men at 40-49 yr of age. In summary, 
we found positive associations between GGT levels at baseline and the change of BP. The 
relation of GGT level and the change of BP was only significant in men, not in women, 
which warrants further studies to elucidate the biologic mechanisms.
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INTRODUCTION
In 2000, more than a quarter of the world’s adult population, 
totaling nearly 1 billion, had hypertension; and this proportion 
will increase to 29% (1.6 billion) by 2025 (1). High blood pres-
sure (BP) is responsible 7.6 million premature deaths and 92 
million disability-adjusted life years (DALYs) in 2001 (2). In ad-
dition, BP change is a common condition that elevates the risk 
of cardiovascular disease (CVD) and mortality in several stud-
ies (3-6). 
 Serum γ-glutamyltransferase (GGT), a commonly used alco-
hol consumption or liver disease, was an established risk factor 
for CVD, such as stroke, myocardial infarction, congestive heart 
failure, metabolic syndrome, and coronary heart disease, sug-
gesting that GGT may be a predictor of CVD (7-9). GGT is also a 
significant risk factor for increase BP (10-13) and incident hy-
pertension (14-19). It is well reported that several cardiovascu-
lar risk factors influences differently according to gender (20). 
Some studies showed that considerable underlying differences 
in the distributions of GGT by gender (21, 22). However, the dif-
ference of the association between GGT and BP by gender is 
unclear. Some previous study has suggested no gender differ-
ences in risk of hypertension (18) while other has shown a dif-
ferent risk in women than in men (12). Moreover most previous 
studies have not been explored gender differences of these as-
sociations (10, 11, 13-17, 19).
 Therefore, we investigated the association between GGT at 
baseline and BP and 4-yr change in BP in a large population and 
assessed whether gender-related difference in this association.
MATERIALS AND METHODS
Study subjects
As a part of the Korean Genome Epidemiology Study, the An-
sung-Ansan cohort study is an ongoing community-based pro-
spective cohort of 10,038 participants aged 40 to 69 yr. The ini-
tial enrollment was carried out in 2001-2002 and follow-up ex-
aminations are conducted biennially. The details of the study 
design and procedures have been previously described (23). 
The current study was based on an examination of baseline and 
second follow-up data. A total of 7,260 subjects was enrolled in 
the current study after the 4-yr follow-up examination; 2,492 
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subjects declined to participate in the follow-up surveys and 
286 died before completing the 2 follow-up visits.
 For accurate observation of association between GGT and BP 
change, 3,067 individuals with hypertension at baseline (BP ≥  
140/90 or use of antihypertensive medications) were excluded. 
In addition, 168 participations with missing information on GGT, 
systolic blood pressure (SBP), diastolic blood pressure (DBP), 
body mass index (BMI), alcohol intake and smoking status at 
baseline and SBP and DBP in the 2 follow-up visits were exclud-
ed. The remaining 4,025 participants (1,945 men and 2,080 wo-
men) are included in this analysis. 
Data collection
Height and weight were measured using standardized techni-
ques and equipment. The BMI was calculated as weight (kg) di-
vided by height squared (m2). BP while the subject was sitting 
and had rested for at least five minutes was measured on 2 oc-
casions 5 min apart using a standard mercury sphygmomano-
meter (Baumanometer; W. A. Baum, Copiague, NY, USA) by 
trained staff; and the mean of value was used for this study. At 
baseline examination, hypertension was defined as BP ≥  140/90 
or use of antihypertensive medications. Blood sample were ob-
tained after a fasting at least 12 hr; serum GGT, triglycerides, high-
density lipoprotein (HDL)-cholesterol and C-reactive protein 
(CRP) were quantified by biochemical assays, performed by a 
central laboratory (Seoul Clinical Laboratories, Seoul, Korea). 
 Demographic characteristic was collected at baseline by train-
ed interviewers; age, gender, cigarette smoking status, alcohol 
consumption (grams/day), menopausal status (yes/no), and 
medication (yes/no). Non-smokers were defined as those who 
had reported “never smoking” in the questionnaire. Former 
smokers were defined as those who had reported “abstain from 
smoking” in the questionnaire. Current smokers were defined 
as those who had reported “currently smoking” in the question-
naire. Alcohol consumption determined based on self-report. 
Subjects were asked how often, on the average, they had con-
sumed the specified amount of each item over the past year. 
Then, alcohol consumption in grams per day was calculated as 
the sum of the average alcohol content per type of alcoholic be-
verage intake multiplied by the daily number of drinks. Meno-
pausal status was also assessed by the self-report. Subjects who 
answered “yes” to the following question: “Do you menstruate?” 
were allotted to premenopausal, and “no” to the question were 
allotted to postmenopausal. 
Statistical analysis
Variables with skewed distribution were log-transformed before 
analysis. Descriptive statistics used to characterize the study sub-
jects included means and SDs for continuous variables and pro-
portions for categorical variables. Comparison between men 
and women were done with t-test or with the  chi-square test. 
Correlations were evaluated with Pearson correlation coefficient.
 Linear regression models were used to examine the associa-
tions of GGT and BP and 4-yr change in BP. We used 3 models. 
First, we performed unadjusted analysis. Second, we adjusted 
for baseline levels of age, BMI, HDL-cholesterol, triglyceride, 
CRP and SBP. Finally, we further adjusted for baseline levels of 
smoking status and alcohol intake.
 Finally we evaluated the association of GGT and BP and 4-yr 
change in BP for subgroups defined by gender, age, menopaus-
al status. All reported P values are two-sided, and P < 0.05 was 
considered statistically significant. Analyses were performed 
using SAS version 9.2 (SAS Institute, Cary, NC, USA). 
Ethics statement
This study was approved by the institutional review board of 
Seoul National University Hospital (IRB No. H1206-081-414) 
and all participants provided written informed consent before 
participation.
RESULTS
Participant characteristics in men and women
Table 1 presents study population characteristics at baseline for 
Table 1. Baseline characteristics of study participants
Parameters All subjects (n = 4,025) Men (n = 1,945) Women (n = 2,080) P value
Age (yr) 50.0 (8.2) 49.9 (8.2) 50.1 (8.3) 0.436
Body mass index (kg/m2) 24.3 (3.0) 24.1 (2.8) 24.4 (3.1) 0.001
HDL cholesterol (mg/dL) 44.8 (9.8) 43.2 (9.6) 46.4 (9.8) < 0.001
Triglycerides (mg/dL)* 126.0 (82.0) 141.0 (95.0) 115.0 (69.0) < 0.001
CRP (mg/dL)* 0.1 (0.2) 0.1 (0.2) 0.1 (0.2) 0.001
GGT (IU/L)* 17.0 (20.0) 28.0 (29.0) 13.0 (8.0) < 0.001
Alcohol intake (grams/day) 9.0 (20.3) 17.3 (26.1) 1.3 (6.1) < 0.001
Systolic blood pressure (mmHg) 112.5 (11.5) 113.7 (10.7) 111.4 (12.1) < 0.001
Diastolic blood pressure (mmHg) 75.0 (8.0) 76.7 (7.4) 73.4 (8.2) < 0.001
Current smoking (No [%]) 1,000 (24.8) 935 (48.1) 65 (3.1) < 0.001
Data are given as mean (SD) unless otherwise indicated. *Median values (interquartile range). P values indicate statistical significance of differences between men and women. 
HDL, high-density lipoprotein; CRP, C-reactive protein; GGT, γ-glutamyltransferase.
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men and women. The mean age of study population was 49.9 
yr in men and 50.1 yr in women at baseline. The BP, triglyceride, 
CRP, GGT levels, and alcohol intake were significantly higher in 
men than in women. Proportions of current smokers were 48.1% 
in men and 3.1% in women. 
 
Associations between baseline GGT and baseline BP
Unadjusted analyses showed that GGT was positively associat-
ed with SBP both in men and in women (P < 0.001, respective-
ly), and regression coefficient is higher in women than in men. 
Also, this relationship remained significant after adjusting for 
age, BMI, HDL-cholesterol, triglyceride, CRP, smoking status, 
and alcohol intake in all subjects (β = 1.28, P < 0.001). There 
was no significant gender difference in the association between 
baseline GGT and baseline SBP (P for interaction with gender 
= 0.829). DBP also showed significant association with GGT 
even after adjusting covariates mentioned above (P < 0.05). GGT 
was not associated with SBP in any age group in men or in wo-
men. However, DBP showed significant association with GGT 
even after adjusting covariates in men younger age group (β =  
0.77, P = 0.037). In the menopausal status-stratified association 
between GGT and BP after adjusted covariates, GGT was not 
Table 2. Four year change in systolic blood pressure in relation to serum γ-glutamyltransferase (GGT) in men and women
Demographic parameters
Unadjusted model Model 1 Model 2
β P value β P value β P value
Total
   40-49 (n = 2,365)
   50-59 (n = 952)
   60-69 (n = 708)
   All age (n = 4,025)
0.84 
1.20 
-0.60 
0.67 
0.006 
0.037 
0.450 
0.010 
1.77 
2.15 
0.16 
1.59 
< 0.001
0.001 
0.834
< 0.001
1.11 
1.65 
0.26 
1.08 
0.002 
0.013 
0.767 
0.001 
Men
   40-49 (n = 1,155)
   50-59 (n = 460)
   60-69 (n = 330)
   All age (n = 1,945)
1.37 
1.59 
1.75 
1.51 
0.003 
0.040 
0.097 
< 0.001
2.13 
2.29 
2.80 
2.30 
< 0.001
0.005 
0.011 
< 0.001
2.30 
1.62 
2.66 
1.82 
< 0.001
0.060 
0.024 
< 0.001
Women
   40-49 (n = 1,210)
   50-59 (n = 492)
   60-69 (n = 378)
   All age (n = 2,080)
0.13 
0.78 
-3.10 
-0.25 
0.829 
0.490
0.035 
0.626 
0.44 
2.43 
-1.55 
0.40 
0.463
0.038 
0.279 
0.434 
0.39 
2.29 
-1.44 
0.38 
0.515
0.052 
0.316 
0.466 
Menopausal status
   Premenopause (n = 753)
   From premenopause (n = 337) to postmenopause
   Postmenopause (n = 966)
0.37 
-0.06 
-1.10 
0.646 
0.965 
0.175 
0.45 
1.73 
0.06 
0.562 
0.170 
0.945 
0.18 
1.52 
0.08 
0.818
0.237 
0.920 
Model 1 adjusted for age, BMI, HDL- cholesterol, triglyceride (log), CRP (log) and SBP; Model 2 adjusted for model 1 plus current smoking status and alcohol intake.
Table 3. Four year change in diastolic blood pressure in relation to serum γ-glutamyltransferase (GGT) in men and women
Demographic parameters
Unadjusted Model Model 1 Model 2
β P value β P value β P value
Total
   40-49 (n = 2,365)
   50-59 (n = 952)
   60-69 (n = 708)
   All age (n = 4,025)
0.52 
0.40 
-0.80 
0.28 
0.024 
0.302 
0.125 
0.129 
1.45 
1.37 
-0.20 
1.19 
< 0.001
0.001
0.685 
< 0.001
0.81 
0.83 
-0.39 
0.64 
0.003 
0.057 
0.474 
0.003 
Men
   40-49 (n = 1,155)
   50-59 (n = 460)
   60-69 (n = 330)
   All age (n = 1,945)
0.93 
0.62 
0.60 
0.93 
0.010 
0.269 
0.393 
0.001 
1.49 
1.29 
1.05 
1.40 
0.001 
0.021 
0.135 
< 0.001
1.09 
0.84 
0.82 
1.05 
0.007 
0.155 
0.270 
0.001 
Women
   40-49 (n = 1,210)
   50-59 (n = 492)
   60-69 (n = 378)
   All age (n = 2,080)
-0.63 
-0.27 
-1.89 
-0.87 
0.172 
0.709 
0.045 
0.016 
-0.24 
0.67 
-1.79 
-0.36 
0.603
0.360
0.042 
0.315 
-0.22 
0.64 
-1.75 
-0.37 
0.627
0.386 
0.048 
0.304 
Menopausal status
   Premenopause (n = 753)
   From premenopause to postmenopause (n = 337) 
   Postmenopause (n = 966)
-0.31 
-1.39 
-0.96 
0.598 
0.165 
0.068 
-0.08 
0.24 
-0.67 
0.898
0.800 
0.188 
-0.16 
0.03 
-0.66 
0.785 
0.979 
0.198 
Model 1 adjusted for age, BMI, HDL- cholesterol, triglyceride (log), CRP (log) and SBP; Model 2 adjusted for model 1 plus current smoking status and alcohol intake.
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covariates, GGT was not associated with BP in premenopause, 
postmenopause or change from premenopause to postmeno-
pause, either. 
DISCUSSION
This study showed gender differences in the relation of baseline 
serum GGT levels to BP change in 4 yr. GGT levels were associ-
ated with BP at baseline after adjusting for age, BMI, HDL-cho-
lesterol, triglyceride, CRP, current smoking status and alcohol 
intake. However, baseline GGT levels were significantly associ-
ated with BP change only in men not in women. This suggests 
that the effect of GGT on BP changes may be somewhat differ-
ent between men and women. 
 Previous studies have shown that GGT has been used as a 
simple marker of alcohol consumption (24) or liver dysfunction 
(25). Recent studies have demonstrated that baseline GGT is 
known as the major risk factor for development of CVD, diabe-
tes, after adjusting for alcohol consumption (7, 16). 
 Several previous cross-sectional and longitudinal studies have 
also reported a positive association of GGT with BP and hyper-
tension (10-19). However, results of these studies on the differ-
ence in the association between men and women did not en-
tirely consistent. Nilssen and Forde reported a positive associa-
tion between GGT and BP only in women, but not in men (12), 
but Shankar and Li found no significant gender difference in 
the association between GGT and BP (18). Others had not stud-
ied separately in men and women but in only men (11, 13, 17) 
or pooled together (10, 14-16, 19). In this study, GGT levels were 
associated with BP at baseline after adjusting for age, BMI, HDL-
cholesterol, triglyceride, CRP, current smoking status and alco-
hol intake in overall population, whereas the statistical signifi-
cance was lost after dividing overall population into men and 
women. That might be result from the reduced sample size and 
overcorrection.
 Our study also showed that there was significant age differ-
ence in the association of GGT with BP changes in men and 
women. Namely, in men, there were positive associations be-
tween GGT and change in SBP among those with age groups 
40-49, 50-59 (borderline significant) and 60-69 yr, but, in wom-
en, only age group 50-59 yr (borderline significant). Generally, 
aging process is associated with a progressive stiffening arterial 
structure, and this process induces a rise in BP (26). In men, our 
study showed that the association of GGT with SBP change was 
stronger in old age groups. Lee et al. showed that clarified the 
complex interaction between GGT, BP and age in men. The study 
demonstrated that the relations of GGT with BP altered by age. 
There were positive associations between GGT and change in 
BP in at or greater than 35 yr old, but in less than 35 yr old (27). 
However, the study was made up in men aged 25 to 50 yr, so it 
seems unreasonable to compare our study. In women, consid-
Table 4. Association between serum γ-glutamyltransferase (GGT) and four year 
change in blood pressure expect the heavy drinker or diagnosed with hepatitis* 
Demographic parameters
Change of SBP Change of DBP
β P value β P value
Total
   40-49 (n = 2,129)
   50-59 (n = 880)
   60-69 (n = 669)
   All age (n = 3,678)
0.90 
1.67 
0.12 
0.94 
0.023 
0.020 
0.900 
0.005 
0.19 
0.26 
-0.99 
0.02 
0.550 
0.599 
0.115 
0.942 
Men
   40-49 (n = 966)
   50-59 (n = 401)
   60-69 (n = 298)
   All age (n = 1,665)
1.72 
1.68 
2.52 
1.90 
0.003
0.088 
0.046 
< 0.001
0.79 
0.51 
0.19 
0.70 
0.104
0.494
0.834
0.056
Women
   40-49 (n = 1,163)
   50-59 (n = 479)
   60-69 (n = 371)
   All age (n = 2,013)
-0.01 
2.33 
-1.47 
0.14 
0.991 
0.051 
0.313 
0.794 
0.70 
0.40 
-1.56 
-0.63 
0.056
0.610 
0.112
0.109
*Adjusted for age, BMI, HDL-cholesterol, triglyceride(log), CRP(log), SBP, current smok-
ing status and alcohol intake. SBP, systolic blood pressure; DBP, diastolic blood pressure.
associated with BP in pre- and post-menopause, either.
Association between baseline GGT and change in BP
Table 2 showed relationship between GGT at baseline and 4-yr 
change in SBP. Remarkably, after adjusting for age, BMI, HDL-
cholesterol, triglyceride, CRP, smoking status, alcohol intake, and 
SBP at baseline, GGT was still positively associated with change 
in SBP in men with statistical significance (P < 0.001), but not 
in women. DBP change also showed significant association with 
GGT even after adjusting covariates mentioned above (P = 0.003) 
(Table 3). There was significant gender difference in this associ-
ation (P for interaction with gender = 0.007). Furthermore, the 
gender difference still remained significant after adjusting body 
weight change during 4 yr (Supplemental Table 1). Also, these 
results still remained constant even when heavy drinkers or do-
cumented hepatitis patients were excluded (Table 4). 
 The age-stratified association between GGT and change in 
SBP is presented Table 2. In unadjusted model, men showed 
significantly positive association in the age groups 40-49 yr and 
50-59 yr, and also positive associating tendency in the age groups 
60-69 yr with marginal significance (P = 0.097). After adjusting 
covariates, men still showed significantly positive association in 
the age groups 40-49 yr and 60-69 yr and also positive associat-
ing tendency in the age groups 50-59 yr with marginal signifi-
cance (P = 0.060). DBP change also showed significant associa-
tion with GGT in age group of 40-49 yr. However, GGT in wo-
men was not associated with change in BP in any age group. Wo-
men showed significantly inverse association in the age group 
60-69 yr (β = -1.75, P = 0.048).
 There was significant age difference in this association in wo-
men (P for interaction with age = 0.021), but not in men (P for 
interaction with age = 0.476). In the menopausal status-strati-
fied association between GGT and change in BP after adjusted 
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ering that on average, natural menopause occurs between the 
ages of 42 and 50 yr in Asian populations (28), the association 
of GGT and BP change in women aged 50 to 59 yr may be ex-
plained change in menopausal status. So, when subdivide by 
menopausal status, we showed the strong positive association 
in change from premenopause to postmenopause, but it was 
not statistically significant.
 In this report, we could not offer the clear mechanism of gen-
der difference in the association between GGT and the BP. How-
ever, we evaluated the association between GGT and other risk 
factors in men and women (Table 5). The association between 
GGT and BP in men still remained significant after adjusting 
BMI and HDL-cholesterol, whereas is no more significant in 
women after adjusting BMI. That finding suggests GGT in men 
might be influenced thus reflects other stress condition such as 
oxidative stress. 
 Although the mechanism of the association between GGT 
and BP remains not fully understood, substantial evidence sup-
ports the biological plausibility of this finding, including an in-
direct role of GGT in initiating extracellular catabolism of anti-
oxidant glutathione in response to oxidative stress (29). So, GGT 
might be a sensitive marker for oxidative stress (30). An experi-
mental study found that oxidative stress have been found with 
higher levels in men (31), the result has been described that test-
osterone increases whereas estrogen inhibits total body oxida-
tive stress (32, 33). In particular, the antioxidant activity of an 
estrogen depends on scavenging free radicals decrease reactive 
oxygen species (32, 34). Longitudinal cohort study and cross-
sectional study also showed an association between menopause 
and BP and change of BP (35, 36). Therefore, a positive associa-
tion of GGT with change in BP may be explained in considering 
the decreasing estrogen by transition from the pre- to the post-
menopausal. Also previous report suggested the association of 
GGT and prehypertension incidence (37).
 Major strengths of this study are the large prospective design, 
the length of follow-up, and the standardized protocol. Addition-
ally, information on all major risk factors was collected. Howev-
er, it has also potential limitations. First, GGT was only measured 
at baseline. Therefore, we were unable to examine for the effect 
change in GGT on BP. Second, the age-related increase in BP 
becomes steeper after the 40 yr old (26), however our study was 
conducted subjects aged 40-69 yr. And four years’ follow up du-
ration might still be too short in confirming gender difference 
in GGT levels and BP change. Finally, we did not consider the 
differences in natural and surgical menopause. 
 In conclusion, the most important findings of this study are 
the gender differences in the association between GGT and the 
change of BP. The definitive reasons for this gender difference 
remain unclear, and require further investigation.
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Supplemental Table 1. Four year change in systolic blood pressure in relation to se-
rum γ-glutamyltransferase (GGT) in men and women (Model adjusted for model 3 
plus body weight change during 4 yr from Table 2).
β P value
Total
   40-49 (n = 2,365)
   50-59 (n = 952)
   60-69 (n = 708)
   All age (n = 4,025)
1.17 
1.59 
0.64 
1.18 
0.001 
0.015 
0.455 
< 0.001
Men
   40-49 (n = 1,155)
   50-59 (n = 460)
   60-69 (n = 330)
   All age (n = 1,945)
1.58 
1.46 
2.32 
1.72 
0.002
0.080 
0.042
< 0.001
Women
   40-49 (n = 1,210)
   50-59 (n = 492)
   60-69 (n = 378)
   All age (n = 2,080)
0.64 
2.22 
-0.64 
0.61 
0.289
0.060 
0.656 
0.237 
Adjusting for age, BMI, HDL-cholesterol, triglyceride (log), CRP (log), SBP, change in 
BMI, current smoking status and alcohol intake.
